Frank Takkinen
Stock Analyst at Lake Street
(1.04)
# 3,670
Out of 4,880 analysts
59
Total ratings
26.92%
Success rate
-10.46%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Assumes: Buy | $30 | $13.98 | +114.67% | 1 | Jun 12, 2025 | |
| ELUT Elutia | Maintains: Buy | $10 → $8 | $2.05 | +290.24% | 3 | May 9, 2025 | |
| SGHT Sight Sciences | Maintains: Hold | $2.5 → $3 | $4.15 | -27.71% | 4 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.89 | +165.20% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $6.03 | +132.17% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $12.72 | +17.92% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $0.68 | +119.43% | 1 | Mar 24, 2025 | |
| AXGN Axogen | Initiates: Buy | $30 | $10.87 | +175.99% | 1 | Mar 17, 2025 | |
| CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $15.84 | +64.14% | 3 | Feb 14, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $17 → $30 | $11.43 | +162.47% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $3.59 | +39.28% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.82 | +424.25% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.22 | +125.23% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $2.00 | +300.00% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $30.88 | -2.85% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.78 | +331.65% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.51 | +298.59% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.15 | +86.48% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $10.64 | +12.78% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $132.14 | +164.87% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $3.77 | +32.63% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.20 | +309.09% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.60 | +900.00% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.61 | +1,413.11% | 2 | Jan 18, 2023 |
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $13.98
Upside: +114.67%
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.05
Upside: +290.24%
Sight Sciences
May 9, 2025
Maintains: Hold
Price Target: $2.5 → $3
Current: $4.15
Upside: -27.71%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.89
Upside: +165.20%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $6.03
Upside: +132.17%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.72
Upside: +17.92%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $0.68
Upside: +119.43%
Axogen
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $10.87
Upside: +175.99%
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $15.84
Upside: +64.14%
ClearPoint Neuro
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $11.43
Upside: +162.47%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.59
Upside: +39.28%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $3.82
Upside: +424.25%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.22
Upside: +125.23%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $2.00
Upside: +300.00%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $30.88
Upside: -2.85%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $2.78
Upside: +331.65%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.51
Upside: +298.59%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.15
Upside: +86.48%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $10.64
Upside: +12.78%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $132.14
Upside: +164.87%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $3.77
Upside: +32.63%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $2.20
Upside: +309.09%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $1.60
Upside: +900.00%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.61
Upside: +1,413.11%